Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey

Prevalence of resistance to rifampicin alone; rifampicin and isoniazid, and second-line anti-TB drugs among sputum smear-positive TB patients

• From: Foreign, Commonwealth & Development Office
• Published: 23 October 2019

• Country: Zimbabwe
• Document Type: Journal Article
• Theme: Health
• First published: 27 July 2019
• Authors: Timire, C, Metcalfe, J.Z., Chirenda, J and Scholten JN,

Abstract

This study aims to determine the prevalence of resistance to rifampicin alone; rifampicin and isoniazid, and second-line anti-TB drugs among sputum smear-positive tuberculosis patients in Zimbabwe.

This research was supported by the UK Department for International Development바카라 사이트™s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Timire C, Metcalfe JZ, Chirenda J, Scholten JN, Manyame-Murwira B, Ngwenya M, Matambo R, Charambira K, Mutunzi H, Kalisvaart N, Sandy C. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey. International Journal of Infectious Diseases. 2019;87:119바카라 사이트“25.

Links

Published 23 October 2019